Michelle A. Herrmann

675 total citations
17 papers, 488 citations indexed

About

Michelle A. Herrmann is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michelle A. Herrmann has authored 17 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michelle A. Herrmann's work include Monoclonal and Polyclonal Antibodies Research (4 papers), TGF-β signaling in diseases (3 papers) and Cancer Cells and Metastasis (3 papers). Michelle A. Herrmann is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), TGF-β signaling in diseases (3 papers) and Cancer Cells and Metastasis (3 papers). Michelle A. Herrmann collaborates with scholars based in United States, Brazil and Malaysia. Michelle A. Herrmann's co-authors include Jin‐Qiu Chen, Paul K. Goldsmith, Madeleine R. Heldman, Peter M. Blumberg, Noémi Kedei, Lalage M. Wakefield, Yu-an Yang, Kathleen C. Flanders, Satyajit Ray and Christina M. Annunziata and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Michelle A. Herrmann

17 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle A. Herrmann United States 11 283 156 67 54 44 17 488
Anwen Liu China 13 276 1.0× 104 0.7× 135 2.0× 75 1.4× 51 1.2× 26 550
Ratna Kumari India 10 200 0.7× 128 0.8× 100 1.5× 32 0.6× 38 0.9× 16 449
Michael Plötz Germany 13 331 1.2× 108 0.7× 55 0.8× 77 1.4× 43 1.0× 18 505
Young‐Choon Moon United States 10 451 1.6× 235 1.5× 140 2.1× 31 0.6× 26 0.6× 23 661
Xiaona Fang China 13 278 1.0× 160 1.0× 113 1.7× 62 1.1× 26 0.6× 20 498
Shuyun Rao United States 13 526 1.9× 157 1.0× 124 1.9× 65 1.2× 40 0.9× 24 722
Jiong Yang China 9 244 0.9× 81 0.5× 132 2.0× 46 0.9× 22 0.5× 14 415
Zhongwei Zhang China 14 288 1.0× 193 1.2× 89 1.3× 66 1.2× 27 0.6× 39 602
Philippe Genne France 15 368 1.3× 262 1.7× 52 0.8× 66 1.2× 34 0.8× 30 632
Fay Habens United Kingdom 9 299 1.1× 106 0.7× 50 0.7× 57 1.1× 36 0.8× 11 477

Countries citing papers authored by Michelle A. Herrmann

Since Specialization
Citations

This map shows the geographic impact of Michelle A. Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Herrmann more than expected).

Fields of papers citing papers by Michelle A. Herrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Herrmann. The network helps show where Michelle A. Herrmann may publish in the future.

Co-authorship network of co-authors of Michelle A. Herrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Herrmann. A scholar is included among the top collaborators of Michelle A. Herrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Herrmann. Michelle A. Herrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yang, Yu-an, Howard H. Yang, Binwu Tang, et al.. (2019). The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models In Vivo Reflects a Complex Balance between Tumor-Suppressive and Proprogression Activities of TGFβ. Clinical Cancer Research. 26(3). 643–656. 20 indexed citations
2.
Čekan, Pavol, Keisuke Hasegawa, Yu Pan, et al.. (2016). RCC1-dependent activation of Ran accelerates cell cycle and DNA repair, inhibiting DNA damage–induced cell senescence. Molecular Biology of the Cell. 27(8). 1346–1357. 39 indexed citations
3.
Sharma, Girdhari M., Prasad Rallabhandi, Kristina M. Williams, Michelle A. Herrmann, & Nakissa Sadrieh. (2016). Gluten Quantitation in Cosmetic Products by Enzyme-Linked Immunosorbent Assay. Journal of AOAC International. 99(3). 586–590. 6 indexed citations
4.
Cataisson, Christophe, Jinqiu Chen, Michelle A. Herrmann, et al.. (2016). Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin. Molecular Carcinogenesis. 55(12). 2183–2195. 9 indexed citations
5.
Flanders, Kathleen C., Yu-an Yang, Michelle A. Herrmann, et al.. (2016). Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium. Oncotarget. 7(25). 38164–38179. 21 indexed citations
6.
8.
Kedei, Noémi, Michelle A. Herrmann, Andrea Telek, et al.. (2014). Molecular Systems Pharmacology: Isoelectric Focusing Signature of Protein Kinase Cδ Provides an Integrated Measure of Its Modulation in Response to Ligands. Journal of Medicinal Chemistry. 57(12). 5356–5369. 4 indexed citations
10.
Chen, Jin‐Qiu, Jih‐Hsiang Lee, Michelle A. Herrmann, et al.. (2013). Capillary Isoelectric-Focusing Immunoassays to Study Dynamic Oncoprotein Phosphorylation and Drug Response to Targeted Therapies in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 12(11). 2601–2613. 24 indexed citations
11.
Kedei, Noémi, Nancy E. Lewin, Tamás Géczy, et al.. (2013). Biological Profile of the Less Lipophilic and Synthetically More Accessible Bryostatin 7 Closely Resembles That of Bryostatin 1. ACS Chemical Biology. 8(4). 767–777. 24 indexed citations
12.
Bakhsheshian, Joshua, Matthew D. Hall, Robert W. Robey, et al.. (2013). Overlapping Substrate and Inhibitor Specificity of Human and Murine ABCG2. Drug Metabolism and Disposition. 41(10). 1805–1812. 35 indexed citations
13.
Chen, Jin‐Qiu, Madeleine R. Heldman, Michelle A. Herrmann, et al.. (2013). Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system. Analytical Biochemistry. 442(1). 97–103. 93 indexed citations
14.
Xin, Hong-Wu, Danielle M. Hari, Gordon Wiegand, et al.. (2013). Label-retaining liver cancer cells are relatively resistant to sorafenib. Gut. 62(12). 1777–1786. 92 indexed citations
15.
Kohn, Ethan A., Yu-an Yang, Zhijun Du, et al.. (2012). Biological Responses to TGF-β in the Mammary Epithelium Show a Complex Dependency on Smad3 Gene Dosage with Important Implications for Tumor Progression. Molecular Cancer Research. 10(10). 1389–1399. 20 indexed citations
16.
Chen, Jin‐Qiu, Jih‐Hsiang Lee, Michelle A. Herrmann, et al.. (2012). A nanofluidic immunoassay system to develop proteomic responsive biomarkers in non-small cell lung cancer.. Journal of Clinical Oncology. 30(30_suppl). 27–27. 2 indexed citations
17.
Peres, Luís Alberto Batista, et al.. (2010). Estudo epidemiológico da doença renal crônica terminal no oeste do Paraná: uma experiência de 878 casos atendidos em 25 anos. Brazilian Journal of Nephrology. 32(1). 51–56. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026